Home › Schizophrenia › Maryland
Pag-aaral pangklinika para sa Schizophrenia sa Maryland
17 pag-aaral para sa Schizophrenia ang naghahanap ng mga kalahok sa mga site sa Maryland.
Mga Lungsod sa Maryland
Opisyal na teksto ng pag-aaral (English)
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- The Johns Hopkins Hospital, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07101094Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0192, Gaithersburg
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07114874A Study of Brenipatide in Adult Participants With Schizophrenia
- CBH Health, Gaithersburg
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07410507A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CBH Health LLC., dba CenExel Gaithersburg MD, Gaithersburg
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Cbh Health - Gaithersburg /ID# 272932, Gaithersburg
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- CenExel Gaithersburg, Gaithersburg
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Gaithersburg
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07459647A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel CBH, Gaithersburg
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07191483Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of Maryland School of Medicine, Baltimore
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 4, 2026 · NCT05208190Synbiotic Compound to Reduce Symptoms of Schizophrenia
- Sheppard Pratt Health System, Batlimore
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT04226898NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT06963034White Matter Plasticity in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
- University of Maryland Baltimore - Maryland Psychiatric Research Center, Catonsville
Nagre-recruit
Edad 15 hanggang 45 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT06641297TMS for Inhibition Enhancement in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
Nagre-recruit
Edad 18 hanggang 45 · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT06155682CBT-CP for Veterans With SMI
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT06758414Study of ALTO-101 in Patients With Schizophrenia
- Site 5062, Gaithersburg
Nagre-recruitPhase 2
Edad 21 hanggang 55 · Lahat ng kasarian · Na-update Dis 26, 2025 · NCT06502964Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Gaithersburg
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 19, 2024 · NCT05184335Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.